Antiretroviral drug market is anticipated to grow at a significant CAGR during the forecast period. Antiretroviral is the category of drugs that are used, act, or are effective against retroviruses particularly to treat HIV. The major driving factors contributing to the market growth include the rising prevalence and burden of HIV, growing investment in R&D related to these drugs coupled with the rise in the availability of novel drugs that pose better efficacy than ever before. These drugs are available in several categories that majorly include Integrase Inhibitors, Protease Inhibitors, Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and others.
According to the US Department of Health & Human Services, in the year 2018, there were nearly 37.9 million people globally living with HIV/AIDS. An estimated 1.7 million individuals globally became newly infected with HIV in 2018. Currently, antiretrovirals are considered to be the basis of HIV/AIDS treatment, since there is no solid cure or a preventive vaccine available for HIV. In the case of a non-resistant strain of HIV, antiretroviral treatment can restrain the replication of HIV in the majority of cases. Thus, the presence of a huge patient pool demands anti-retroviral drugs for the treatment which is projected to drive the growth of the market during the forecast period.
Some key players operating in the market include AbbVie Inc., Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.
To Request a Sample of our Report on Antiretroviral Drug Market: https://www.omrglobal.com/request-sample/antiretroviral-drug-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
- Segment Covered
- Regions Covered- Globally
- Competitive Landscape: AbbVie Inc., Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Gilead Sciences, among others.
Antiretroviral Drug Market by Segments
By Drug Class
- Integrase Inhibitors
- Protease Inhibitors
- Multi-class Combination Products
- Nucleoside Reverse Transcriptase Inhibitors
- Non-Nucleoside Reverse Transcriptase Inhibitors
- Others
A full Report of Antiretroviral Drug Market is Available at: https://www.omrglobal.com/industry-reports/antiretroviral-drug-market
Antiretroviral Drug Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
